Quantcast

Latest pharmaceutical industry Stories

2015-01-12 08:29:47

Companies Committed to Providing Access to Colchicine Tablets CINCINNATI and DEERFIELD, Ill., Jan.

2015-01-12 08:29:28

CHARLOTTESVILLE, Va., Jan. 12, 2015 /PRNewswire/ -- HemoShear, a privately held discovery stage biotechnology company, announced today a multi-year platform collaboration with Pfizer Inc.

2015-01-12 08:29:24

-- First Observation of Dose Limiting Toxicity Signals VAL-083's Potential Advancement Toward Registration Directed Clinical Trials in Refractory Glioblastoma -- VANCOUVER, British Columbia

2015-01-12 04:21:25

- Novartis returns Alisporivir (DEB025) to Debiopharm Group(TM) including all rights for HCV and other indications - LAUSANNE, Switzerland, January 12, 2015 /PRNewswire/ --

2015-01-09 23:02:35

The 2015 CNPR Program looks to break the mold of ‘boring’ online pharmaceutical sales training with an updated manuals and online platforms. New York, NY

2015-01-09 23:00:20

Rnrmarketresearch.com adds “Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015” to its store.

2015-01-09 12:24:26

LYNDHURST, N.J., Jan.

2015-01-09 12:24:25

TARRYTOWN, N.Y., Jan. 9, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc.


Word of the Day
postliminy
  • In Roman antiquity, the return of a person who had been banished, or taken prisoner by an enemy, to his old condition and former privileges.
  • In international law, that right by virtue of which persons and things taken by an enemy in war are restored to their former status when coming again under the power of the nation to which they belonged.
The word 'postliminy' comes from a Latin word meaning 'threshold'.